Leveraging BODIPY nanomaterials for enhanced tumor photothermal therapy

J Mater Chem B. 2021 Sep 22;9(36):7318-7327. doi: 10.1039/d1tb00855b.

Abstract

In the past ten years, photothermal therapy (PTT) has attracted widespread attention in tumor treatment due to its non-invasiveness and little side effects. PTT utilizes heat produced by photothermal agents under the irradiation of near-infrared light to kill tumor cells. Boron-dipyrromethene (BODIPY), an organic phototherapy agent, has been widely used in tumor phototherapy due to its higher molar extinction coefficient, robust photostability and good phototherapy effect. However, there are some issues in the application of BODIPY for tumor PTT, such as low photothermal conversion efficiency and short absorption wavelength. In this review, we focus on the latest development of BODIPY nanomaterials for overcoming the above problems and enhancing the PTT effect.

Publication types

  • Review

MeSH terms

  • Animals
  • Boron Compounds / chemistry*
  • Cell Survival / drug effects
  • Humans
  • Infrared Rays
  • Nanostructures / chemistry*
  • Nanostructures / therapeutic use
  • Nanostructures / toxicity
  • Neoplasms / drug therapy*
  • Photothermal Therapy / methods
  • Polymers / chemistry

Substances

  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Boron Compounds
  • Polymers